MabCure Elects Dr. David Frank to Its Board

MabCure, Inc. (MabCure), a biotechnology company using its proprietary technology to create highly specific monoclonal antibodies (MAbs) for the early detection of cancer, said that it welcomes Dr. David S. Frank to the company's board of directors.

Dr. Frank has held a number of senior level executive positions at public companies. Most recently he assumed the position of Managing Director at the privately held MEDx Associates , a diagnostics and medical devices consulting company. Prior to that Dr. Frank served as Executive Director of Business Development at Ortho Clinical Diagnostics, a Johnson & Johnson company.

Dr. Frank's industrial career began as a founding member of Kodak's thin film diagnostics research and development team, where, over a nine-year period he was granted ten patents. As Director of Marketing and Planning Management at Kodak Clinical Diagnostics from 1982-1994, Dr. Frank served as head of point of care diagnostics; regional business manager for Asia, Africa, and Australia; and Director of Diagnostics Marketing for Japan. Dr. Frank, who earned his biochemistry PhD from Cornell University, recently served as a faculty member at the LAHAV-Tel Aviv University Graduate School of Business, where he taught at health care marketing courses for bioscience entrepreneurs.

Dr. Frank is currently the Chairman of the Board of Nehora Photonics, a medical device company located in Israel, and a board member of TogetherForever .

"We are delighted to welcome David to the board," said Dr. Amnon Gonenne, MabCure's President and CEO. "David's breadth of international business development and marketing experience is certain to be instrumental to the future of MabCure. With David's ship and expertise, we anticipate the company will accelerate toward the achievement of the shared goals of our shareholders, employees, customers, and patients alike."

((Comments on this story may be sent to health@closeupmedia.com))

Related terms: africa, asia, australia, biology, biotechnology, business, cancer, career, ceo, clinical, consulting, executive, film, health, industrial, israel, japan, marketing, medical, president, research and development, ship, technology, university